Skip to main content

Media

Latest News

March 25, 2023

U.S. Rep. Joe Neguse visited the Pulliam Community Building in downtown Loveland on Friday afternoon, after the federal government funding bill that included an allocation for the historic building was passed earlier this month.


March 24, 2023

Washington, D.C. — Today, co-chairs of the Bipartisan Wildfire Caucus, Representatives Joe Neguse (D-CO) and John Curtis (R-UT) announced the re-launch of the caucus in the 118th Congress.


March 23, 2023

Lafayette, CO — Today, Colorado lawmakers Congressman Joe Neguse and Senators Michael Bennet and John Hickenlooper introduced a resolution expressing support for the designation of ‘Clela Rorex Day,’ honoring the contributions of former Boulder County Clerk, Clela Rorex – a pioneer for civil rights and same-sex marriage.


March 22, 2023

Lafayette, CO — Congressman Joe Neguse issued the following statement on the second anniversary of the devastating mass shooting at the Table Mesa King Soopers in Boulder, Colorado that claimed the lives of 10 members of the community: 


March 19, 2023
Newsletter

Dear Neighbor, It has been wonderful seeing so many of you over the past week as we’ve traversed the district, visiting with constituents, small-businesses, local leaders and more. In every interaction, I’m reminded of the work folks are doing to put politics aside and put community first — and I couldn’t be more proud to do the same!  


March 17, 2023

U.S. Rep. Joe Neguse of Colorado is asking housing officials to update federal mortgage guidelines that are leaving Marshall Fire victims at risk of foreclosure.


March 17, 2023

Lafayette, CO — This week, Congressman Joe Neguse wrote to Federal Housing Administration (FHA) Commissioner Julia Gordon, requesting an update to the Home Equity Conversion Mortgage (HECM) occupancy requirements for borrowers following a natural disaster.


March 16, 2023

DENVER (KDVR) — Insulin prices continue to drop. A third pharmaceutical company said it will drastically cut the cost of the important drug.

French company Sanofi said it would be cutting the list price for its most prescribed insulin product, Lantus, by 78%, according to FOX31’s partners at The Hill.